RVTY · News · 20260804N
AI Drug Discovery Demand
REVVITY, INC. · 2026-08-04 · Importance 31 · Surprise 42
Revvity is seeing increasing orders tied to AI-driven drug-discovery platforms. The demand supports its life sciences tools and high-content screening offerings used by pharmaceutical and biotechnology researchers. AI-related activity was described as an incremental contributor rather than the primary growth driver, with Diagnostics remaining the stronger segment. The reports did not identify a specific major customer or geographic market associated with the AI orders.